Regulatory Updates on Compounded Peptides New Drug Loft and VLS Pharmacy FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step Deep Dive: Regulatory Status of Popular Compounded Peptides Holt Law FDA's Overreach on Compounded Peptides Gray Market Peptides: So Much Hype, So Little Data